Labs / CDMO: development & manufacturing
ScinoPharm Taiwan, Ltd.
Tainan, Taiwan · scinopharm.com
GLP · GMP
ScinoPharm Taiwan, Ltd. develops and manufactures high-barrier APIs and drug products, with integrated CDMO and CMC services for global pharmaceutical clients. The company is headquartered in Tainan, Taiwan, and also operates API manufacturing facilities in Taiwan and Changshu, China.
They take quote requests by email.
What they offer
API development and manufacturing
Develops and manufactures high-potency APIs, including oncology, CNS, cardiovascular, orphan drug, small molecule, and peptide products.
Drug product development and manufacturing
Develops and manufactures injectable drug products, including sterile and high-potency injectables.
CDMO services
Provides end-to-end contract development and manufacturing from process development and clinical sample preparation to commercial-scale production.
CMC capabilities and support
Offers one-stop CMC solutions including technical guidance, regulatory support, market authorization application, and post-launch process improvement.
Contract analytical testing services
Provides cGMP-compliant analytical testing as part of its CDMO offering.
What they work on
- Modalities
- Small molecule, Peptide
- Assays and studies
- analytical testing, cGMP-compliant analytical testing, process hazard analysis, safety testing, toxicity prediction
- Instruments and platforms
- differential scanning calorimeters, reaction calorimeters, adiabatic calorimeters (PHI-TEC II), eQMS, Derek Nexus, Sarah Nexus for Windows, 10 m2 freeze-dryer (lyophilizer)
- Scale and capacity
- 18 CGMP-compliant production lines, reactors ranging from 20 L to 10,000 L, batches from a few grams to metric ton scale, production capacity up to 200 kg per year, maximum capacity of 7,800 units per hour for 1 mL products, maximum batch size of approximately 19,000 units for 10R ISO vials
- Therapeutic areas
- oncology, hematology, central nervous system disorders, metabolic diseases, cardiovascular, orphan diseases
- Type
- CRDMO
- Sites
- Tainan, Taiwan · Changshu, China
- Team
- over 100 scientists and researchers
- Quality
- FDA (inspections, approval, and cGMP compliance) · EMA (approval and cGMP compliance) · PMDA (approval and cGMP compliance) · PIC/S GMP (manufacturing compliance) · ICH Q10 (quality management) · TFDA (requirements and inspections) · cGMP (manufacturing compliance) · ISO/IEC 27001:2022 (Information Security Management System (ISMS) Certification) · PSCI (passed audits by pharmaceutical partners) · Responsible Care® (environment, health, and safety initiative)
- Serves
- worldwide, U.S., Europe, over 100 countries
- Founded
- 1997
Public records
Similar labs. ARSI Canada Inc, Aurigene Pharmaceutical Services, CordenPharma, DSK InnoSciences
Found in a contract services directory. Listing built from scinopharm.com. Work here? Claim this listing.